Role of Inflammation in PML
Status: Completed
Location: See location...
Study Type: Observational
SUMMARY
This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• PML patients of 18 years of age or older will be included in this study.
Locations
United States
Massachusetts
Beth Israel Deaconess Medical Center
Boston
Time Frame
Start Date: 2004-06
Completion Date: 2018-12
Participants
Target number of participants: 126
Treatments
PML
These are subjects who have confirmed PML.
Control
These are subjects who do not have PML. They may be healthy or immune compromised due to Cancer, Transplant, or HIV.
Authors
Related Therapeutic Areas
Sponsors
Collaborators: National Institutes of Health (NIH)
Leads: Beth Israel Deaconess Medical Center